Richard A. Morgan. Ex vivo applications of Cas12a. Presented at the Keystone Symposia: Engineering the Genome, February 8-12, 2020.

Aug

30

Editas Medicine Announces Upcoming Investor Events

Aug

2

Editas Medicine Announces Second Quarter 2023 Results and Business Updates

Jul

27

Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization